Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Last data update: Sep 26, 2021. (Total: 42473 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1-30 (of 266 Records)

Next

Query Trace: Cardiomyopathy[original query]>>Translation/Implementation Studies[Product Type]
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial
CY Ho et al, Nature Medicine, September 23, 2021
Psychological Distress and Quality of Life in Participants Undergoing Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy Caused by TMEM43 p.S358L: Is It Time to Offer Population-Based Genetic Screening?
Brothers Cassidy et al. Public health genomics 2021 1-8
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
Nauffal Victor et al. European heart journal 2021
Estimating the Population Benefits of Blood Pressure Lowering: A Wide-Angled Mendelian Randomization Study in UK Biobank.
Higgins Hannah et al. Journal of the American Heart Association 2021 e021098
Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy.
Arabadjian Milla E et al. Journal of the American Heart Association 2021 e019978
Yield of Bone Scintigraphy Screening for Transthyretin-related Cardiac Amyloidosis in Different Conditions: Methodological Issues and Clinical Implications.
Tini Giacomo et al. European journal of clinical investigation 2021 e13665
Genomic Autopsy of Sudden Deaths in Young Individuals.
Webster Gregory et al. JAMA cardiology 2021
Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of ECG Risk-score and HCMRisk-Kids score.
Östman-Smith Ingegerd et al. Acta paediatrica (Oslo, Norway : 1992) 2021
Explanatory Analysis of a Machine Learning Model to Identify Hypertrophic Cardiomyopathy Patients from EHR Using Diagnostic Codes.
Farahani Nasibeh Zanjirani et al. Proceedings. IEEE International Conference on Bioinformatics and Biomedicine 2021 20201932-1937
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy.
Smole Tim et al. Computers in biology and medicine 2021 135104648
Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy.
Stroeks Sophie L V M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2021
Development and evaluation of decision aids to guide families' predictive testing choices for children at risk for arrhythmia or cardiomyopathy.
Christian Susan et al. The Canadian journal of cardiology 2021
Phenotype and progression among patients with dilated cardiomyopathy and RBM20 mutations.
Robles-Mezcua Ainhoa et al. European journal of medical genetics 2021 64(9) 104278
Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy
SLVM Stroeks et al, Genetics in Medicine, June 30, 2021
Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.
Bhattacharya Moumita et al. CJC open 2021 3(6) 801-813
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
Parker Margaret M et al. Scientific reports 2021 11(1) 11645
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity.
Scott Erika N et al. NPJ genomic medicine 2021 6(1) 35
Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy.
Xiao Lei et al. Frontiers in cardiovascular medicine 2021 8657689
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Spertus John A et al. Lancet (London, England) 2021
Actionable secondary findings in arrhythmogenic right ventricle cardiomyopathy genes: impact and challenge of genetic counseling.
Abicht Angela et al. Cardiovascular diagnosis and therapy 2021 11(2) 637-649
A radiomic approach to predict myocardial fibrosis on coronary CT angiography in hypertrophic cardiomyopathy.
Qin Le et al. International journal of cardiology 2021
Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study.
Ware Stephanie M et al. Journal of the American Heart Association 2021 e017731
Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
Hathaway Julie et al. BMC cardiovascular disorders 2021 21(1) 126
Diagnostic yield of targeted next generation sequencing in 2002 Dutch cardiomyopathy patients.
Alimohamed Mohamed Z et al. International journal of cardiology 2021
Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant.
Lamounier Junior Arsonval et al. Revista espanola de cardiologia (English ed.) 2021
Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM): A Study from the ClinGen Cardiomyopathy Variant Curation Expert Panel.
Morales Ana et al. The Journal of molecular diagnostics : JMD 2021
Automatic multilabel detection of ICD10 codes in Dutch cardiology discharge letters using neural networks.
Sammani Arjan et al. NPJ digital medicine 2021 4(1) 37
Clinical and laboratory reporting impact of ACMG-AMP and modified ClinGen variant classification frameworks in MYH7-related cardiomyopathy.
Richmond Christopher M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2021 Feb
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features.
Ghidoni Alice et al. Circulation. Genomic and precision medicine 2021 Feb
Impact of the creation of specialized units for patients with hypertrophic cardiomyopathy.
Negreira-Caamaño Martín et al. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2021 Jan
TOP